Press Release 01.31.2023
Patients 01.31.2023
Patients 01.24.2023
Science & Innovation 01.19.2023
Amgen's clinical trial program investigates a potential first-in-class mechanism of action for moderate to severe atopic dermatitis.
Science & Innovation 01.18.2023
Often referred to as the founder of BiTE® technology, the Amgen Research Munich scientist received the George B. Rathmann Award for Scientific Excellence at a recent leadership meeting.
PRESS RELEASE
Amgen is a pioneer in the science of using living cells to make biologic medicines.
Amgen’s medicines treat serious illnesses and typically address diseases with a limited number of treatment options.
Making a positive difference in the world is at the heart of what we do at Amgen—and it goes beyond making vital medicines.
Amgen is a pioneer in the science of using living cells to making biologic medicines, leading and guiding the biotech industry.
Encounter opportunities both new and undiscovered, as we embrace leading-edge technologies, invest in our talents, and maximize our potential.
